Hi Fidelity Genetics
Hi Fidelity Genetics provides premium non-GMO corn and soybean seeds for farmers, offering farm-direct pricing that cuts seed costs significantly compared to corporate seed companies. The company leverages its predictive breeding platform, including the RootTracke root analysis system and Luther AI breeding engine, to develop high-performance crop varieties that deliver competitive yields at lower costs. The…
Funding snapshot
About
Hi Fidelity Genetics provides premium non-GMO corn and soybean seeds for farmers, offering farm-direct pricing that cuts seed costs significantly compared to corporate seed companies. The company leverages its predictive breeding platform, including the RootTracke root analysis system and Luther AI breeding engine, to develop high-performance crop varieties that deliver competitive yields at lower costs. The platform measures crop-specific and environmental parameters to build plant growth models using predictive analytics, collecting and screening trillions of data combinations on proprietary corn plants fed into advanced data science pipelines. By focusing on non-GMO genetics and straightforward pricing with no hidden fees, minimum order quantities, or gimmicks, the company gives farmers access to premium genetics that make economic sense for their operations. The company offers knowledgeable sales support and fast farm-direct shipping. Founded in 2014 and headquartered in Durham, United States, the company has raised approximately $8.5M in Series A funding from investors including Fall Line Capital, Finistere Ventures, S2G Investments, KdT Ventures, and ARPA-E.
Business model
Genomics > Applied Genomics > Agrigenomics,
Crop Tech > Farm Inputs > Plant Breeding > Management Solutions > Analytics
Team background
College Wise > Harvard University
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Hi Fidelity Genetics?
Analyze your pitch deck before your next raise.
Analyze My Deck →